The aporphine alkaloid boldine improves endothelial function in spontaneously hypertensive rats

Experimental Biology and Medicine

Volumn 237, Issue 1, 2012, Pages 93-98

  Lau, Yeh Siang ^a   Machha, Ajay ^b   Achike, Francis I ^c   Murugan, Dharmani ^a   Mustafa, Mohd Rais ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Blood pressure; Boldine; Endothelial function; Hypertension; Oxidative stress

Indexed keywords

ACETYLCHOLINE; BOLDINE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; PROTEIN P47; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; HEART MUSCLE RELAXATION; HYPERTENSION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ACETYLCHOLINE; ANIMALS; ANTIOXIDANTS; APORPHINES; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HYPERTENSION; MALE; NADPH OXIDASE; NITROPRUSSIDE; OXIDATIVE STRESS; PEROXYNITROUS ACID; RANDOM ALLOCATION; RATS; RATS, WISTAR; SUPEROXIDES; VASODILATION;

ANIMALIA; PEUMUS BOLDUS; RATTUS;

EID: 84855848781     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011145     Document Type: Article

References (33)

1. Lip GY, Felmeden DC, Li-Saw-Hee FL, Beevers DG. Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'? Eur Heart J 2000;21:1653-65.
2. Armitage ME, Wingler K, Schmidt HH, La M. Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. J Mol Med 2009;87:1071-6.
3. Gewaltig MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 2002;55:250-60.
4. Ferroni P, Basili S, Paoletti V, Davi G. Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc 2006;16:222-33.
5. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008;10:1115-26.
6. O'Brien P, Carrasco-Pozo C, Speisky H. Boldine and its antioxidant or health-promoting properties. Chem Biol Interact 2006;159:1-17.
7. Speisky H, Cassels BK. Boldo and boldine: an emerging case of natural drug development. Pharmacol Res 1994;29:1-12.
8. Santanam N, Penumetcha M, Speisky H, Parthasarathy S. A novel alkaloid antioxidant, boldine and synthetic antioxidant, reduced form of RU486, inhibit the oxidation of LDL in vitro and atherosclerosis in vivo in LDLR(2/2) mice. Atherosclerosis 2004;173:203-10.
9. Ivorra MD, Martinez F, Serrano A, D'Ocon P. Different mechanism of relaxation induced by aporphine alkaloids in rat uterus. J Pharm Pharmacol 1993;45:439-43.
10. Mukhtar MR, Martin M-T, Domansky M, Pais M, Hamid A, Hadi A, Awang K. Phoebegrandines A and B, proaporphine-tryptamine dimers, from Phoebe grandis. Phytochemistry 1997;45:1543-6.
11. Ivorra MD, Chulia S, Lugnier C, D'Ocon MP. Selective action of two aporphines at alpha 1-adrenoceptors and potential-operated Ca2{thorn} channels. Eur J Pharmacol 1993;231:165-74.
12. Chulia S, Moreau J, Naline E, Noguera MA, Ivorra MD, D'Ocon MP, Advenier C. The effect of S-({thorn})-boldine on the alpha 1-adrenoceptor of the guinea-pig aorta. Br J Pharmacol 1996;119:1305-12.
13. Woodman OL, Malakul W. 30,40-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta. Life Sci 2009;85:54-9.
14. Yeh-Siang L, Subramaniam G, Hadi AHA, Murugan D, Mustafa MR. Reactive oxygen species-induced impairment of endothelium-dependent relaxations in rat aortic rings: protection by methanolic extracts of Phoebe grandis. Molecules 2011;16:2990-3000.
15. Radi R, Cosgrove TP, Beckman JS, Freeman BA. Peroxynitrite-induced luminol chemiluminescence. Biochem J 1993;290(Part 1):51-7.
16. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004;15:1983-92.
17. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997;95:588-93.
18. Akpaffiong MJ, Taylor AA. Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am J Hypertens 1998;11:1450-60.
19. Fujii S, Zhang L, Igarashi J, Kosaka H. L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension 2003;42:1014-20.
20. Lassèguea B, Griendling KK. Reactive oxygen species in hypertension: an update. Am J Hypertens 2004;17:852-60.
21. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II infused mice. J Hypertens 2004;22:535-42.
22. Suzuki H, Swei A, Zweifach BW, Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension 1995;25:1083-9.
23. Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006;21:269-80.
24. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller A. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol 2004;165:219-26.
25. Jang YY, Song JH, Shin YK, Han ES, Lee CS. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacol Res 2000;42:361-71.
26. Estelles R, Milian L, Nabah YN, Mateo T, Cerda-Nicolas M, Losada M, Ivorra MD, Issekutz AC, Cortijo J, Morcillo EJ, Blazquez MA, Sanz MJ. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo. J Leuk Biol 2005;78:696-704.
27. Lau YS, Achike FI, Dharmani M, Mustafa MR. Endothelial protective effects of boldine in streptozotocin-induced diabetic rat: free radical scavenging activities and inhibition of protein kinase C (introduced by Owen L Woodman, RMIT University, Australia). Ascept Annual Scientific Meeting, 2010, Melbourne, Australia
28. Guzik TJ, Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 2006;11:524-33.
29. Forstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 2008;5:338-49.
30. Ajay M, Achike FI, Mustafa AM, Mustafa MR. Direct effects of quercetin on impaired reactivity of spontaneously hypertensive rat aortae: comparative study with ascorbic acid. Clin Exp Pharmacol Physiol 2006;33:345-50.
31. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 1996;20:443-8.
32. Hansen K, Nedergaard OA. Methodologic aspects of acetylcholine-evoked relaxation of rabbit aorta. J Pharmacol Toxicol Methods 1999;41:153-9.
33. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986;78:1-5